Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...

Earlier today, Co-Diagnostics released financial results from the third quarter ended 09/30/2025. In addition to diagnostic ...

Explore how oligonucleotides are reshaping therapeutics, diagnostics and CRISPR with rapid, scalable and personalized solutions across biotech.

Primerdesign (part of the Novacyt Group), a company focussed on the design, manufacture, validation and supply of real-time ...

The Angelman syndrome (AS) and the Prader-Willi syndrome (PWS) are distinct neurogenetic disorders which are caused by a deficiency of maternal (AS) or paternal (PWS) contributions for chromosome 15.

Co-Diagnostics, Inc. ("Co-Diagnostics," "Co-Dx," or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced ...

Ultrafiltration membranes used in pharmaceutical manufacturing and other industrial processes have long relied on separating ...

A research team led by the A*STAR Genome Institute of Singapore (A*STAR GIS) have developed a method to accurately and ...

Scientists found that DNA’s phosphate groups can direct chemical reactions to make the correct mirror-image form of drug ...